NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Nanowear Wearable Covid-19 Observational and Analysis Trend
The Nanowear Wearable Covid-19 Observational and Analysis Trend

NCT04717024

TerminatedN/A

Sponsor: Nanowear Inc.

Conditions: Covid19

Interventions: Observational Study - no intervention

Countries: United States

The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Subject has provided informed consent
* Male or female over the age of 18 years
* The patient is currently hospitalized with a primary diagnosis of Covid-19

Exclusion Criteria:

* Subject is unwilling or unable to wear the vest during hospitalization.
* Subjects who are pregnant.
* Subject is intubated or admitted to ICU
* Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)
Locations (2)
  • Hackensack, New Jersey, United States
  • Brooklyn, New York, United States